Skip to content
10-Q

Quarterly Report

Humanigen, Inc.

0001214659-23-007002

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 3, 2023 119.08M sh
Shares Diluted Q1 2023 · Mar 31, 2023 119.08M sh
Shares Diluted Q1 2023 · Mar 31, 2022 65.59M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$7.06M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$19.44M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $3.1M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $10.16M
Stockholders Equity Q1 2023 · Mar 31, 2023 −$49.73M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$46.77M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$25.05M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$23.69M
Current Liabilities Q1 2023 · Mar 31, 2023 $53.3M
Current Liabilities Q1 2023 · Dec 31, 2022 $56.19M
Total Liabilities Q1 2023 · Mar 31, 2023 $54.84M
Total Liabilities Q1 2023 · Dec 31, 2022 $57.96M
Current Assets Q1 2023 · Mar 31, 2023 $5.03M
Current Assets Q1 2023 · Dec 31, 2022 $11.11M
Total Assets Q1 2023 · Mar 31, 2023 $5.12M
Total Assets Q1 2023 · Dec 31, 2022 $11.2M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.04
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.32
Eps Basic Q1 2023 · Mar 31, 2023 −$0.04
Eps Basic Q1 2023 · Mar 31, 2022 −$0.32
Sga Expense Q1 2023 · Mar 31, 2023 $3.72M
Sga Expense Q1 2023 · Mar 31, 2022 $4.35M
Rd Expense Q1 2023 · Mar 31, 2023 $737K
Rd Expense Q1 2023 · Mar 31, 2022 $17.22M
Net Income Q1 2023 · Mar 31, 2023 −$4.18M
Net Income Q1 2023 · Mar 31, 2022 −$21.28M
Operating Income Q1 2023 · Mar 31, 2023 −$4.24M
Operating Income Q1 2023 · Mar 31, 2022 −$20.53M
Revenue Q1 2023 · Mar 31, 2023 $221K
Revenue Q1 2023 · Mar 31, 2022 $1.04M